• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Soligenix Inc

+ Add to Watchlist

DOA1:GR

1.444 EUR 0.004 0.28%

As of 09:07:44 ET on 07/10/2014.

Snapshot for Soligenix Inc (DOA1)

Open: 1.444 Day's Range: 1.444 - 1.444 Volume: 0
Previous Close: 1.448 52wk Range: 0.740 - 1.900 1-Yr Rtn: +94.35%

Stock Chart for DOA1

No chart data available.
  • DOA1:GR 1.444
  • 1D
  • 1M
  • 1Y
1.448
Interactive DOA1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DOA1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4550
Est. PEG Ratio -
Market Cap (M EUR) 28.78
Shares Outstanding (M) 19.93
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DOA1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DOA1

Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.

Christopher J SchaberChairman/President/CEORichard StraubeSenior VP/Chief Medical Ofcr
Robert N BreySenior VP/Chief Scientific OfcrJoseph M WaruszVP:Finance/Acting CFO
More Company Profile & Key Executives for DOA1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil